Epilepsy & behavior : E&B
January 22, 2026
Fredrik K Andersson, Bisrat Ezra, Kenney Roy Roodakker et al.
Ecstatic seizures (EcS) have captured scientific interest due to their potential origin in anterior insular networks, emphasizing the insula's role in self-processing. Their frequency in epilepsy or insular pathology has not been systematically studied. Present study aimed to examine the frequency and clinical characteristics of EcS in epilepsy patients, and the potential occurrence of ecstatic...
BMC Psychology
January 21, 2026
Christina Chwyl, Angelica Spata, Will Lucas et al.
Findings indicate a "mindset-over-molecule" pattern wherein psychological context ("set") is more strongly associated with psychedelic outcomes than substance type alone.
Psychedelic Medicine
January 12, 2026
Kelsey T. Laird, Prabha Siddarth, Ashley Ramos et al.
Objective: Emerging evidence suggests that mystical experiences mediate the therapeutic effects of psychedelic-assisted therapy. The current study examines associations between mystical experiences and components of “set” (positive mindset, participant intentions, and spirituality) and “setting” (perceived positivity of the dosing environment) in the context of psilocybin-assisted therapy for...
Journal of Applied Consciousness Studies
2026
G. Raj, Hemant Bhargav
1 citation
Data from previous psychedelic trials suggests that the intensity of mystical experiences positively impacts treatment outcomes. However, not many conceptual frameworks are available to measure how this seems to be the case. According to Yogic and Buddhist philosophies, Kleshas are considered obstacles to self-realization, inner peace, and liberation. Using validated questionnaires, we accessed...
The International journal on drug policy
2026
Guy Simon, Nir Tadmor, Demian Halperin
2 citations
Psychedelics induce transformative experiences leading to lasting changes in attitudes and behaviour, with outcomes depending on both pharmacological factors and the context of the experience ('set and setting'), marking a paradigm shift in mental health treatment. As psychedelics transition from traditional contexts to clinical settings, tension emerges between authenticity and...
Philosophical Psychology
2026
Juensung J. Kim, Kadi Tulver, Jaan Aru et al.
1 citation
We argue that the powerful transformative effects of mystical-type experiences can be understood using the same machinery that underlies insight problem solving, and that both mystical experiences and insight are species of a genus of “realization experiences”: experiences wherein some phenomenon or piece of information becomes suddenly experienced as real or true. Specifically, we argue that...
General Hospital Psychiatry
2026
Rebeca Cohen, João Bastos, Catarina Cunha et al.
1 citation
Ketamine, an N-methyl-d-aspartate antagonist, shows promise for treatment-resistant depression (TRD), with psychedelic doses potentially enhancing efficacy. However, its transient antidepressant effects and the need for repeated infusions raise concerns about optimal duration and long-term safety. Two clinical trials have tested the combination of ketamine with psychotherapy for depression,...